Second primary cancers after an index head and neck cancer: Subsite-specific trends in the era of human papillomavirus - Associated oropharyngeal cancer

Journal of Clinical Oncology

Volumn 29, Issue 6, 2011, Pages 739-746

  Morris, Luc G T ^a   Sikora, Andrew G ^a   Patel, Snehal G ^a   Hayes, Richard B ^a   Ganly, Ian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRONCHUS CANCER; CANCER LOCALIZATION; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; SEER PROGRAM;

EID: 79952132576     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.8311     Document Type: Article

References (45)

1. Vikram B: Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 110:564-565, 1984
2. León X, Quer M, Diez S, et al: Second neoplasm in patients with head and neck cancer. Head Neck 21:204-210, 1999 (Pubitemid 29144579)
3. Sturgis EM, Miller RH: Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 104:946-954, 1995
4. Garavello W, Ciardo A, Spreafico R, et al: Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132:762-766, 2006 (Pubitemid 44086440)
5. Ha PK, Califano JA: The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 14:363-369, 2003 (Pubitemid 44560790)
6. Slaughter DP, Southwick HW, Smejkal W: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963-968, 1953
7. Boice JD Jr, Fraumeni JF Jr: Second cancer following cancer of the respiratory system in Connecticut, 1935-1982. Natl Cancer Inst Monogr 68: 83-98, 1985
8. Veli EM, Schatzkin A: Common environmental risk factors, in Neugut AI (ed): Multiple Primary Cancers. Philadelphia, PA, Lippincott Williams & Wilkins, 1999, pp 213-223
9. Tepperman BS, Fitzpatrick PJ: Second respiratory and upper digestive tract cancers after oral cancer. Lancet 2:547-549, 1981 (Pubitemid 11052786)
10. Gluckman JL, Crissman JD: Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract. Laryngoscope 93:71-74, 1983 (Pubitemid 13221702)
11. Chuang SC, Scelo G, Tonita JM, et al: Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer 123:2390-2396, 2008
12. Cooper JS, Pajak TF, Rubin P, et al: Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 17:449-456, 1989 (Pubitemid 19227546)
13. de Vries N, Snow GB: Multiple primary tumours in laryngeal cancer. J Laryngol Otol 100:915-918, 1986
14. de Vries N, Van der Waal I, Snow GB: Multiple primary tumours in oral cancer. Int J Oral Maxillofac Surg 15:85-87, 1986
15. Lin K, Patel SG, Chu PY, et al: Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 27:1042-1048, 2005 (Pubitemid 41705581)
16. Rennemo E, Zätterström U, Boysen M: Impact of second primary tumors on survival in head and neck cancer: An analysis of 2,063 cases. Laryngoscope 118:1350-1356, 2008
17. Jones AS, Morar P, Phillips DE, et al: Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 75:1343-1353, 1995
18. Hashibe M, Brennan P, Chuang SC, et al: Interaction between tobacco and alcohol use and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 18:541-550, 2009
19. Lubin JH, Purdue M, Kelsey K, et al: Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: A pooled analysis of case-control studies. Am J Epidemiol 170:937-947, 2009
20. Purdue MP, Hashibe M, Berthiller J, et al: Type of alcoholic beverage and risk of head and neck cancer: A pooled analysis within the INHANCE Consortium. Am J Epidemiol 169:132-142, 2009
21. Ang KK, Harris J, Wheeler R, et al: Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35, 2010
22. Chung CH, Gillison ML: Human papillomavirus in head and neck cancer: Its role in pathogenesis and clinical implications. Clin Cancer Res 15:6758-6762, 2009
23. Gillison ML, Koch WM, Capone RB, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709-720, 2000 (Pubitemid 30365531)
24. Jemal A, Clegg LX, Ward E, et al: Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101:3-27, 2004
25. Harlan LC, Hankey BF: The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. J Clin Oncol 21:2232-2233, 2003 (Pubitemid 46621856)
26. Clegg LX, Reichman ME, Miller BA, et al: Impact of socioeconomic status on cancer incidence and stage at diagnosis: Selected findings from the surveillance, epidemiology, and end results-National Longitudinal Mortality Study. Cancer Causes Control 20:417-435, 2009
27. Fritz A, Percy C, Jack A: International Classification of Diseases for Oncology. Geneva, World Health Organization, 2000
28. Warren S, Gates O: Multiple primary malignant tumors: A survey of the literature and a statistical study. Am J Cancer 16:1358-1414, 1932
29. Curtis RE, Ries LA: Methods, in Curtis RE, Freedman DM, Ron E, et al (eds): New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD, National Cancer Institute, 2006, pp 9-14
30. Schoenberg BS, Myers MH: Statistical methods for studying multiple primary malignant neoplasms. Cancer 40:1892-1898, 1977 (suppl)
31. Begg CB, Zhang ZF, Sun M, et al: Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. Am J Epidemiol 142:653-665, 1995
32. Breslow NE, Day NE: Statistical Methods in Cancer Research (vol 2): The Design and Analysis of Cohort Studies. Lyon, France, International Association for Research on Cancer, 1987, pp 69-70
33. Kim HJ, Fay MP, Feuer EJ, et al: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335-351, 2000 (Pubitemid 30070608)
34. Braakhuis BJ, Tabor MP, Leemans CR, et al: Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions. Head Neck 24:198-206, 2002 (Pubitemid 34111517)
35. Haughey BH, Gates GA, Arfken CL, et al: Meta-analysis of second malignant tumors in head and neck cancer: The case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101: 105-112, 1992
36. Yamamoto E, Shibuya H, Yoshimura R, et al: Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer 94:2007-2014, 2002
37. CDC grand rounds: Current opportunities in tobacco control. MMWR Morb Mortal Wkly Rep 59:487-492, 2010
38. Ernster JA, Sciotto CG, O'Brien MM, et al: Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 117:2115-2128, 2007 (Pubitemid 351339584)
39. Näsman A, Attner P, Hammarstedt L, et al: Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma? Int J Cancer 125: 362-366, 2009
40. Maxwell JH, Kumar B, Feng FY, et al: Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res 16:1226-1235, 2010
41. Licitra L, Perrone F, Bossi P, et al: High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24:5630-5636, 2006 (Pubitemid 46631302)
42. Fakhry C, Westra WH, Li S, et al: Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269, 2008 (Pubitemid 351480538)
43. Lindquist D, Romanitan M, Hammarstedt L, et al: Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 1:350-355, 2007 (Pubitemid 350186274)
44. Chen MC, Huang WC, Chan CH, et al: Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer. Oral Oncol 46:249-254, 2010
45. Erkal HS, Mendenhall WM, Amdur RJ, et al: Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol 19:1358-1362, 2001 (Pubitemid 32202541)